6-Chloro-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine, 90.0%, 1g

6-Tritylamino-nicotinic acid, 98.0%, 1g

Ethyl 2-(5-bromopyrimidin-4-yl)acetate, 95.0%, 5g

3-(2,6-difluorophenyl)-1,2-oxazol-5-ol, 95.0%, 2g

2H,3H,5H,6H,7H,8H-pyrido[4,3-c]pyridazin-3-one hydrochloride, 98%, 250mg

Ethyl 2-amino-5-isopropoxybenzoate, 95+%, 50mg

Formic acid, min. 98%, for synthesis, 5 l, plastic packaging.

5-Cyclopropyl-1,3,4-thiadiazol-2-amine, 97.0%, 1g

Guanethidine sulphate, 98.0%, 1g

z-d-asp-ome, 97.0%, 10g

2,3-Dihydropyrazolo[5,1-b][1,3]oxazol-6-ylmethanol, 1g

2-Bromooctadecanoic acid, 97.0%, 1g

1,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 5g